| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18908b0cea0b414ca6e332fe9ed7ad96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a13479c58c71914f95114497b301ea75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c122eb351b62eef8c0a1ce9090f84d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a70b05f3bdf7f6e9aaf7a41ac3aacdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa483f86cc4003166ba4a17f7117bc12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32c8074617958fd27763c00e2cd0f29a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2006-08-08^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33b0ba45d0a3b261b3b606bcad433637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5544cd249035685e15b73d4450f40ea8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c21ca82f7b04ef47ae1b960b7104d94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3f809972da56190761da7dd4abe70f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d034dc0f560f4c92d86ec133a802e94c |
| publicationDate |
2007-04-05^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007017513-A3 |
| titleOfInvention |
Formulations for 7-(t-butoxy)iminomethyl camptothecin |
| abstract |
The present invention relates to nanoparticulate compositions in which the active agent is a topoisomerase I inhibitor and pharmaceutical compositions comprising the nanoparticulate compositions that are useful for the treatment and prevention of proliferative diseases including cancer. |
| priorityDate |
2005-08-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |